BRCA mutation screening and patterns among high-risk Lebanese subjects
ConclusionTheBRCA1 c.131G > T mutation can be considered a founder mutation in the Lebanese population detected among 5/17 (29%) of individuals diagnosed with a mutation inBRCA1 and among 7/269 families in this cohort. On review of recently published data regarding the landscape ofBRCA mutations in the Middle East and North Africa, each region appears to have a unique spectrum of mutations.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research
More News: African Health | Breast Cancer | Cancer | Cancer & Oncology | Genetics | Lebanon Health | Middle East Health | Palestine Health | Study | USA Health